InvestorsHub Logo
Followers 46
Posts 6263
Boards Moderated 0
Alias Born 06/17/2009

Re: None

Monday, 11/29/2021 7:00:56 AM

Monday, November 29, 2021 7:00:56 AM

Post# of 1124
FYI

NRx Pharmaceuticals Identifies Significantly Higher Likelihood of Surviving and Recovering from Critical COVID-19 in ZYESAMI® (aviptadil) Treated Patients Previously Administered Remdesivir



https://finance.yahoo.com/news/nrx-pharmaceuticals-identifies-significantly-higher-113100540.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRXP News